Publication of manuscript on preclinical Proof-of-Concept of arimoclomol in Gaucher disease
27 nov. 2018 08h51 HE
|
ORPHAZYME A/S
Orphazyme A/SInvestor news No....
Orphazyme reports encouraging arimoclomol clinical trial top-line data in Niemann-Pick disease Type C (NPC)
28 sept. 2018 01h00 HE
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Orphazyme to Present at 25th NPUK Annual Family Conference 2018
20 sept. 2018 09h19 HE
|
ORPHAZYME A/S
Orphazyme A/SInvestor news No....
Orphazyme announces enrollment of first patient in Phase III clinical trial of arimoclomol for ALS
10 août 2018 12h19 HE
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Publication of manuscript related to Phase II trial results for arimoclomol in patients with SOD1 ALS
24 janv. 2018 16h06 HE
|
ORPHAZYME A/S
Investor newsOrphazyme A/SNo. 01/2018 ...